Tyrone Gayle

Mylan NV (NASDAQ: MYL) has been making the wrong kind of headlines this week. Democratic presidential nominee Hillary Clinton singled out Mylan for its 400 percent increase in the price of EpiPens in recent years. “It’s wrong when drug companies put profits ahead of patients, raising...